Author:
Zhao Fangzhou,Li Jun,Tang Lei,Li Chunming,Wang Wenying,Ning Chen
Funder
Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Cochat P, Liutkus A, Fargue S, Basmaison O, Ranchin B, Rolland MO (2006) Primary hyperoxaluria type 1: still challenging! Pediatr Nephrol 21:1075–1081. https://doi.org/10.1007/s00467-006-0124-4
2. Leumann E, Hoppe B (2005) Primary hyperoxaluria type 1: is genotyping clinically helpful? Pediatr Nephrol 20:555–557. https://doi.org/10.1007/s00467-005-1813-0
3. Amoroso A, Pirulli D, Florian F, Puzzer D, Boniotto M, Crovella S, Zezlina S, Spanò A, Mazzola G, Savoldi S, Ferrettini C, Berutti S, Petrarulo M, Marangella M (2001) AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J Am Soc Nephrol 12:2072–2079
4. Dindo M, Conter C, Oppici E, Ceccarelli V, Marinucci L, Cellini B (2019) Molecular basis of primary hyperoxaluria: clues to innovative treatments. Urolithiasis 47:67–78. https://doi.org/10.1007/s00240-018-1089-z
5. Beck BB, Hoyer-Kuhn H, Göbel H, Habbig S, Hoppe B (2013) Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions. Expert Opin Investig Drugs 22:117–129. https://doi.org/10.1517/13543784.2013.741587
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献